Long Read Sequencing Revolutionizing Genomic Applications

 

Long Read Sequencing 

Advanced Gene Sequencing Opens New Avenues

Next-generation sequencing technologies have revolutionized genomics research over the past decade. However, short read lengths have posed challenges for complex genomic applications. Long read sequencing is now addressing these challenges by generating ultra-long reads, up to hundreds of kilobases in length. This enables phasing of entire human genomes and de novo assembly of complex genomes without referencing a reference genome.

Long reads facilitate new applications across medicine, agriculture, forensic analysis and more. Long Read Sequencing  are transforming our understanding of structural variations, microbiomes, epigenetics and disease pathogenesis. This article discusses the key capabilities and applications of leading third generation sequencing platforms and the genomic insights they are enabling. It also examines industry trends and analysts' projections on the growing adoption and impact of this transformative technology.

Resolving Structural Variations

One of the most significant applications is resolving complex structural variations that were difficult to characterize with short reads. Long reads can reveal large indels, inversions, duplications and other complex structural variants associated with diseases and traits. They enable phasing of variants across entire human genomes to discern inherited haplotypes.

Complete de novo Assembly

Another major capability is generating reference-quality genomes through complete de novo assembly without relying on a reference. This has enabled assembly of numerous bacterial, viral, plant and animal genomes directly from native DNA or RNA withoutculture or isolation. De novo assembly also reconstructs complete fungal, protozoan and other pathogen genomes directly from clinical samples.

Single-Cell Genomics

Long reads are empowering single-cell genomics applications by allowing comprehensive characterization and phasing of genomes from individual cells. This facilitates studies of genomic heterogeneity, mechanisms of drug resistance, neuronal diversity, cancer evolution and more. When combined with expression profiling, they can reconstruct full transcriptomes from single cells.

Microbiome Analysis

Long reads provide an unprecedented view of microbiomes by enabling assembly of nearly complete genomes from microbial communities directly from native samples. This has revolutionized our understanding of complex human, environmental and industrial microbiomes and the interactions within such polymicrobial communities. It also facilitates strain-level epidemiological tracking.

Epigenomic Insights

By producing long reads that span entire gene regions and complexes, these systems are enabling comprehensive profiling and phasing of epigenetic markers like DNA methylation and histone modifications. This yields novel insights into regulation of gene expression, splicing, imprinting and X-chromosome inactivation with implications for development, disease and toxicology studies.

Clinical Utility

In clinical genetics, long reads are augmenting molecular diagnosis by resolving disease-causing structural variants, long-range phasing of disease loci, detecting fusion transcripts, and reconstructing viral quasispecies directly from patient samples. Large academic medical centers and diagnostic laboratories are adopting them for complex genetic testing. Their utility for non-invasive prenatal testing and cancer surveillance is also being explored.

Technology Trends

The three leading platforms for long read sequencing are Oxford Nanopore Technologies' (ONT) MinION and PromethION, Pacific Biosciences (PacBio) Sequel II and Illumina's soon-to-be-launched long read technology. ONT offers the most portable solution while PacBio delivers the highest read lengths. Both continue advancing throughput and read lengths annually. Illumina's new system aims to combine long reads with their proven throughput.

This will be driven by improving affordability and widespread adoption across clinical, industrial and research applications requiring complete genome information. Multiple companies are developing nanopore arrays and other innovations to further boost throughput. Long reads are expected to increasingly supplement and in some cases replace short read technologies for relevant applications.

In conclusion, third generation long read sequencing technologies have revolutionized genomic research capabilities. They are addressing limitations faced with short reads and enabling novel applications across medicine, biotechnology and other industries. Technological advances continue expanding the power and affordability of third generation sequencing. With its ability to generate complete genomic information directly from native samples, this disruptive technology is foundational to precision medicine and our broad understanding of genomics.

 

Get more insights on This Topic- Global Long Read Sequencing